FilingReader Intelligence

Glenmark Pharmaceuticals hit by $37.75m US litigation settlement

August 14, 2025 at 07:07 PM UTCBy FilingReader AI

Glenmark Pharmaceuticals reported flat revenue growth of 0.6% to INR 32,644 million in Q1, with adjusted profit of INR 3,129 million hit by a $37.75 million US litigation settlement.

The company approved transferring its Consumer Care business to a new wholly-owned subsidiary for approximately INR 240.40 crores.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Glenmark Pharmaceuticals publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →